We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR Reveals New Targets for Promising Cancer Drugs

News   Jul 20, 2017 | Original story from Harvard University

 
CRISPR Reveals New Targets for Promising  Cancer Drugs

redit: Haining Lab, Dana-Farber/Boston Children’s Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different CRISPR-Cas9-mediated gene knocked out. T cells (red) destroy the cancer cells that have had essential immune evasion genes knocked out.

 
 
 

RELATED ARTICLES

Epigenetic Signature May Help People Stay Ahead of IBD

News

In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.

READ MORE

Decoding the Structure of an RNA-Based CRISPR System

News

Over the past several years, CRISPR-Cas9 has moved beyond the lab bench and into the public zeitgeist. Now, scientists from the Salk Institute are reporting for the first time the detailed molecular structure of CRISPR-Cas13d, a promising enzyme for emerging RNA-editing technology.

READ MORE

Fire, Sun or Electricity Powers Hand-held Cancer Detection Device

News

Device shows promise as a point-of-care detector of Kaposi sarcoma-associated herpesvirus in resource-limited settings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE